诺瓦瓦克斯2019冠状病毒病疫苗 (Chinese Wikipedia)

Analysis of information sources in references of the Wikipedia article "诺瓦瓦克斯2019冠状病毒病疫苗" in Chinese language version.

refsWebsite

Global rank Chinese rank

46web.archive.org

1^st place

7doi.org

2^nd place

23^rd place

5worldcat.org

5^th place

12^th place

5reuters.com

49^th place

81^st place

5nih.gov

4^th place

5^th place

2sciencemag.org

857^th place

506^th place

2bizjournals.com

407^th place

1,299^th place

2cnbc.com

220^th place

426^th place

2ltn.com.tw

302^nd place

6^th place

2cna.com.tw

527^th place

24^th place

2novavax.com

low place

2europa.eu

68^th place

209^th place

1indiatoday.in

94^th place

1,782^nd place

1livemint.com

390^th place

4,697^th place

1nature.com

234^th place

227^th place

1bbc.com

20^th place

41^st place

1un.org

97^th place

122^nd place

1harvard.edu

18^th place

57^th place

1fancycomma.com

low place

1docs.google.com

1,047^th place

1,169^th place

1milkeninstitute.org

low place

1fiercepharma.com

low place

1nytimes.com

7^th place

31^st place

1clinicaltrials.gov

5,225^th place

4,888^th place

1statnews.com

8,771^st place

9,752^nd place

1swissinfo.ch

1,485^th place

1,674^th place

1rthk.hk

2,797^th place

109^th place

1who.int

195^th place

179^th place

1hk01.com

379^th place

11^th place

1washingtonpost.com

34^th place

129^th place

1theguardian.com

12^th place

60^th place

1gazettelive.co.uk

5,758^th place

low place

1thisistherealspain.com

low place

1bloomberg.com

99^th place

225^th place

1yna.co.kr

981^st place

190^th place

1cp24.com

8,625^th place

8,137^th place

1expressandstar.com

3,534^th place

7,097^th place

1thestandnews.com

4,504^th place

168^th place

1udn.com

392^nd place

10^th place

1163.com

372^nd place

16^th place

163.com (Global: 372^nd place; Chinese: 16^th place)

欧洲药管局：美国诺瓦瓦克斯新冠疫苗可能导致严重过敏. [2022-07-16]. （原始内容存档于2022-07-16）.

bbc.com (Global: 20^th place; Chinese: 41^st place)

New Covid vaccine shows 89% efficacy in UK trials. BBC News. 2021-01-28 [2021-01-28]. （原始内容存档于2021-04-29）.

bizjournals.com (Global: 407^th place; Chinese: 1,299^th place)

Gilgore S. Novavax is working to advance a potential coronavirus vaccine. So are competitors.. Washington Business Journal. 2020-02-26 [2020-03-06]. （原始内容存档于2020-03-16）.
Gilgore S. Novavax's coronavirus vaccine program is getting some help from Emergent BioSolutions. Washington Business Journal. 2020-03-10 [2020-03-10]. （原始内容存档于2020-04-09）.

bloomberg.com (Global: 99^th place; Chinese: 225^th place)

Novavax Deal With Mabion Boosts Poland’s Nascent Biotech Scene. Bloomberg. 2021-03-25 [2021-04-05]. （原始内容存档于2021-03-09）.

clinicaltrials.gov (Global: 5,225^th place; Chinese: 4,888^th place)

Clinical trial number NCT04611802 for "A Study Looking at the Efficacy, Immune Response, and Safety of a COVID-19 Vaccine in Adults at Risk for SARS-CoV-2" at ClinicalTrials.gov

cna.com.tw (Global: 527^th place; Chinese: 24^th place)

蘇龍麒. 陳時中證實採購Novavax疫苗逾200萬劑抵台時間待定. 中央社. 2022-03-24 [2022-06-20]. （原始内容存档于2022-06-22）.
張茗喧. 幼兒莫德納估7月中下旬開打 Novavax最快7月到貨. 中央社. 2022-06-18 [2022-06-20]. （原始内容存档于2022-06-30）.

cnbc.com (Global: 220^th place; Chinese: 426^th place)

Novavax starts clinical trial of its coronavirus vaccine candidate. CNBC. 2020-05-25 [2020-05-26]. （原始内容存档于2020-05-26）.
Lovelace B. Novavax says Covid vaccine is more than 89% effective. CNBC. 2020-01-28 [2021-04-05]. （原始内容存档于2021-01-30）.

cp24.com (Global: 8,625^th place; Chinese: 8,137^th place)

Canada signs deal to produce Novavax COVID-19 vaccine at Montreal plant. CP24. 2021-02-02 [2021-02-02]. （原始内容存档于2021-04-28）.

docs.google.com (Global: 1,047^th place; Chinese: 1,169^th place)

COVID-19 vaccine tracker (click on 'Vaccines' tab). Milken Institute. 2020-05-11 [2020-05-12]. （原始内容存档于2020-06-06）. 简明摘要.

doi.org (Global: 2^nd place; Chinese: 23^rd place)

Novavax’s fridge-friendly vaccine impresses. Nature Biotechnology. 2021-07, 39 (7): 784–784 [2021-08-30]. ISSN 1087-0156. doi:10.1038/s41587-021-00991-8. （原始内容存档于2021-07-27）（英语）.
Wadman, Meredith. Novavax vaccine delivers 89% efficacy against COVID-19 in U.K.—but is less potent in South Africa. Science. 2021-01-28 [2021-08-30]. ISSN 0036-8075. doi:10.1126/science.abg8101. （原始内容存档于2021-05-25）.
Wadman M. The long shot. Science. November 2020, 370 (6517): 649–653. Bibcode:2020Sci...370..649W. PMID 33154120. doi:10.1126/science.370.6517.649 .
Wadman M. Novavax launches pivotal U.S. trial of dark horse COVID-19 vaccine after manufacturing delays. Science. 2020-12-28 [2021-04-05]. doi:10.1126/science.abg3441. （原始内容存档于2021-05-13）.
Chung, Young Hun; Beiss, Veronique; Fiering, Steven N.; Steinmetz, Nicole F. COVID-19 Vaccine Frontrunners and Their Nanotechnology Design. ACS Nano. 2020-10-09 [2021-08-30]. ISSN 1936-0851. PMC 7553041 . PMID 33034449. doi:10.1021/acsnano.0c07197. （原始内容存档于2021-10-19）.
Medhi R, Srinoi P, Ngo N, Tran HV, Lee TR. Nanoparticle-Based Strategies to Combat COVID-19. ACS Applied Nano Materials. 2020-09-25, 3 (9): 8557–8580. PMC 7482545 . doi:10.1021/acsanm.0c01978.
Keech, Cheryl; Albert, Gary; Cho, Iksung; Robertson, Andreana; Reed, Patricia; Neal, Susan; Plested, Joyce S.; Zhu, Mingzhu; Cloney-Clark, Shane. Phase 1–2 Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine. New England Journal of Medicine. 2020-12-10, 383 (24): 2320–2332. ISSN 0028-4793. PMC 7494251 . PMID 32877576. doi:10.1056/NEJMoa2026920.

europa.eu (Global: 68^th place; Chinese: 209^th place)

ema.europa.eu

Nuvaxovid COVID-19 Vaccine (recombinant, adjuvanted). EMA. 2021-12-20 [2021-12-22]. （原始内容存档于2021-12-23）.

ec.europa.eu

Coronavirus: Commission approves new contract for a potential COVID-19 vaccine with Novavax. European Commission. 2021-08-04 [2021-08-04]. （原始内容存档于2020-08-25）（英语）.

expressandstar.com (Global: 3,534^th place; Chinese: 7,097^th place)

GSK to support manufacture of Novavax Covid-19 jab at Barnard Castle facility. Express & Star. 2021-03-29 [2021-04-05]. （原始内容存档于2021-03-29）.

fancycomma.com (Global: low place; Chinese: low place)

Parekh N. Novavax: A SARS-CoV-2 Protein Factory to Beat COVID-19.. 2020-07-24 [2020-07-24]. （原始内容存档于2020-11-22）.

fiercepharma.com (Global: low place; Chinese: low place)

Sagonowsky E. Novavax scores $384M deal, CEPI's largest ever, to fund coronavirus vaccine work. FiercePharma. 2020-05-11 [2020-05-12]. （原始内容存档于2020-05-16）.

gazettelive.co.uk (Global: 5,758^th place; Chinese: low place)

Brown M. 60m doses of new covid-19 vaccine could be made in Billingham – and be ready for mid-2021. TeesideLive (Reach). 2020-08-14 [2021-01-29]. （原始内容存档于2021-02-07）.

harvard.edu (Global: 18^th place; Chinese: 57^th place)

ui.adsabs.harvard.edu

Wadman M. The long shot. Science. November 2020, 370 (6517): 649–653. Bibcode:2020Sci...370..649W. PMID 33154120. doi:10.1126/science.370.6517.649 .

hk01.com (Global: 379^th place; Chinese: 11^th place)

新冠肺炎｜歐盟批准使用Novavax疫苗. 香港01. 2021-12-21 [2021-12-21]. （原始内容存档于2021-12-21）.

indiatoday.in (Global: 94^th place; Chinese: 1,782^nd place)

Covovax trials begin in India, launch hopefully in September: Adar Poonawalla. India Today. 2021-03-27 [2021-03-28]. （原始内容存档于2021-05-14）.

livemint.com (Global: 390^th place; Chinese: 4,697^th place)

Hope to launch Covovax by September, says Serum Institute CEO. mint. 2021-03-27 [2021-03-28]. （原始内容存档于2021-05-13）.

ltn.com.tw (Global: 302^nd place; Chinese: 6^th place)

news.ltn.com.tw

諾瓦瓦克斯證實︰台灣早透過COVAX訂購疫苗. 自由時報. 2021-07-03 [2021-07-08]. （原始内容存档于2021-07-11）.
吳亮儀. 首批50.4萬劑Novavax疫苗抵台檢驗封緘照片曝光. 自由時報. 2022-06-30 [2022-06-30]. （原始内容存档于2022-06-30）.

milkeninstitute.org (Global: low place; Chinese: low place)

COVID-19 vaccine tracker (click on 'Vaccines' tab). Milken Institute. 2020-05-11 [2020-05-12]. （原始内容存档于2020-06-06）. 简明摘要.

nature.com (Global: 234^th place; Chinese: 227^th place)

Novavax’s fridge-friendly vaccine impresses. Nature Biotechnology. 2021-07, 39 (7): 784–784 [2021-08-30]. ISSN 1087-0156. doi:10.1038/s41587-021-00991-8. （原始内容存档于2021-07-27）（英语）.

nih.gov (Global: 4^th place; Chinese: 5^th place)

ncbi.nlm.nih.gov

Wadman M. The long shot. Science. November 2020, 370 (6517): 649–653. Bibcode:2020Sci...370..649W. PMID 33154120. doi:10.1126/science.370.6517.649 .
Chung, Young Hun; Beiss, Veronique; Fiering, Steven N.; Steinmetz, Nicole F. COVID-19 Vaccine Frontrunners and Their Nanotechnology Design. ACS Nano. 2020-10-09 [2021-08-30]. ISSN 1936-0851. PMC 7553041 . PMID 33034449. doi:10.1021/acsnano.0c07197. （原始内容存档于2021-10-19）.
Medhi R, Srinoi P, Ngo N, Tran HV, Lee TR. Nanoparticle-Based Strategies to Combat COVID-19. ACS Applied Nano Materials. 2020-09-25, 3 (9): 8557–8580. PMC 7482545 . doi:10.1021/acsanm.0c01978.
Keech, Cheryl; Albert, Gary; Cho, Iksung; Robertson, Andreana; Reed, Patricia; Neal, Susan; Plested, Joyce S.; Zhu, Mingzhu; Cloney-Clark, Shane. Phase 1–2 Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine. New England Journal of Medicine. 2020-12-10, 383 (24): 2320–2332. ISSN 0028-4793. PMC 7494251 . PMID 32877576. doi:10.1056/NEJMoa2026920.

nih.gov

Phase 3 trial of Novavax investigational COVID-19 vaccine opens. National Institutes of Health (NIH). 2020-12-28 [2020-12-28]. （原始内容存档于2021-01-19）.

novavax.com (Global: low place; Chinese: low place)

novavax.com

Urgent global health needs addressed by Novavax. Novavax. [2021-01-30]. （原始内容存档于2021-05-12）.

ir.novavax.com

Novavax and European Commission Finalize Advance Purchase Agreement for up to 200 million doses of COVID-19 Vaccine - Aug 4, 2021. novavax.com. 2021-08-04 [2021-08-04]. （原始内容存档于2021-08-09）（英语）.

nytimes.com (Global: 7^th place; Chinese: 31^st place)

Thomas K, Zimmer C. Novavax Enters Final Stage of Coronavirus Vaccine Trials. The New York Times. 2020-09-24 [2020-09-28]. ISSN 0362-4331. （原始内容存档于2020-09-28）.

reuters.com (Global: 49^th place; Chinese: 81^st place)

Steenhuysen J. U.S. government awards Novavax $1.6 billion for coronavirus vaccine. Reuters. 2020-07-07 [2020-09-15]. （原始内容存档于2020-09-14）.
O’Donnell, Carl; Nadeem, Dania. Novavax vaccine 96% effective against original coronavirus, 86% vs British variant in UK trial. Reuters. 2021-03-11 [2021-03-23]. （原始内容存档于2021-05-04）.
Novavax signs COVID-19 vaccine supply deal with India's Serum Institute. Reuters. 2020-08-05 [2021-04-05]. （原始内容存档于2021-03-19）.
Reuters. Novavax COVID-19 vaccine receives first emergency use authorization. Reuters. 2021-11-01 [2021-11-01]. （原始内容存档于2021-12-24）（英语）.
Philippines approves emergency use of Novavax's COVID-19 vaccine. Reuters. 2021-11-17 [2021-11-17]. （原始内容存档于2021-12-23）.

rthk.hk (Global: 2,797^th place; Chinese: 109^th place)

news.rthk.hk

諾瓦瓦克斯公布其研發的新冠疫苗有效率逾九成. [2021-06-15]. （原始内容存档于2021-06-16）.

sciencemag.org (Global: 857^th place; Chinese: 506^th place)

Wadman, Meredith. Novavax vaccine delivers 89% efficacy against COVID-19 in U.K.—but is less potent in South Africa. Science. 2021-01-28 [2021-08-30]. ISSN 0036-8075. doi:10.1126/science.abg8101. （原始内容存档于2021-05-25）.
Wadman M. Novavax launches pivotal U.S. trial of dark horse COVID-19 vaccine after manufacturing delays. Science. 2020-12-28 [2021-04-05]. doi:10.1126/science.abg3441. （原始内容存档于2021-05-13）.

statnews.com (Global: 8,771^st place; Chinese: 9,752^nd place)

Facher L, Joseph A. Novavax says its Covid-19 vaccine is 90% effective in late-stage trial. Stat. 2021-01-28 [2021-01-29]. （原始内容存档于2021-01-29）.

swissinfo.ch (Global: 1,485^th place; Chinese: 1,674^th place)

诺瓦瓦克斯声称疫苗经试验100%能预防重症. SWI swissinfo.ch. 瑞士资讯. [2021-05-13]. （原始内容存档于2021-05-13）（中文）.

theguardian.com (Global: 12^th place; Chinese: 60^th place)

Boseley S, Davis N. Novavax Covid vaccine shown to be nearly 90% effective in UK trial. The Guardian. 2021-01-28 [2021-01-29]. （原始内容存档于2021-04-12）.

thestandnews.com (Global: 4,504^th place; Chinese: 168^th place)

專家指政府有意採購第 4 款疫苗採重組蛋白技術料為「美國 Novavax」或「成都威斯克」. 立場新聞. 2021-03-13 [2021-03-13]. （原始内容存档于2021-03-14）.

thisistherealspain.com (Global: low place; Chinese: low place)

Spain, again chosen to produce the vaccine to combat COVID-19. This is the Real Spain. 2020-09-18 [2021-04-05]. （原始内容存档于2021-03-19）.

udn.com (Global: 392^nd place; Chinese: 10^th place)

不只從COVAX取得諾瓦瓦克斯疫苗陳時中：正與原廠談判. 聯合報. 2021-07-02 [2021-07-08]. （原始内容存档于2021-07-09）.

un.org (Global: 97^th place; Chinese: 122^nd place)

news.un.org

世卫组织将第十种新冠疫苗列入紧急使用清单. 聯合國新聞. 2021-12-21 [2022-01-01]. （原始内容存档于2022-04-17）.

washingtonpost.com (Global: 34^th place; Chinese: 129^th place)

McCartney R. Maryland plays an outsized role in worldwide hunt for a coronavirus vaccine. Washington Post. [2020-05-08]. （原始内容存档于2020-05-07）.

web.archive.org (Global: 1^st place; Chinese: 1^st place)

Covovax trials begin in India, launch hopefully in September: Adar Poonawalla. India Today. 2021-03-27 [2021-03-28]. （原始内容存档于2021-05-14）.
Hope to launch Covovax by September, says Serum Institute CEO. mint. 2021-03-27 [2021-03-28]. （原始内容存档于2021-05-13）.
Novavax’s fridge-friendly vaccine impresses. Nature Biotechnology. 2021-07, 39 (7): 784–784 [2021-08-30]. ISSN 1087-0156. doi:10.1038/s41587-021-00991-8. （原始内容存档于2021-07-27）（英语）.
Wadman, Meredith. Novavax vaccine delivers 89% efficacy against COVID-19 in U.K.—but is less potent in South Africa. Science. 2021-01-28 [2021-08-30]. ISSN 0036-8075. doi:10.1126/science.abg8101. （原始内容存档于2021-05-25）.
New Covid vaccine shows 89% efficacy in UK trials. BBC News. 2021-01-28 [2021-01-28]. （原始内容存档于2021-04-29）.
世卫组织将第十种新冠疫苗列入紧急使用清单. 聯合國新聞. 2021-12-21 [2022-01-01]. （原始内容存档于2022-04-17）.
Wadman M. Novavax launches pivotal U.S. trial of dark horse COVID-19 vaccine after manufacturing delays. Science. 2020-12-28 [2021-04-05]. doi:10.1126/science.abg3441. （原始内容存档于2021-05-13）.
Parekh N. Novavax: A SARS-CoV-2 Protein Factory to Beat COVID-19.. 2020-07-24 [2020-07-24]. （原始内容存档于2020-11-22）.
Chung, Young Hun; Beiss, Veronique; Fiering, Steven N.; Steinmetz, Nicole F. COVID-19 Vaccine Frontrunners and Their Nanotechnology Design. ACS Nano. 2020-10-09 [2021-08-30]. ISSN 1936-0851. PMC 7553041 . PMID 33034449. doi:10.1021/acsnano.0c07197. （原始内容存档于2021-10-19）.
Urgent global health needs addressed by Novavax. Novavax. [2021-01-30]. （原始内容存档于2021-05-12）.
Gilgore S. Novavax is working to advance a potential coronavirus vaccine. So are competitors.. Washington Business Journal. 2020-02-26 [2020-03-06]. （原始内容存档于2020-03-16）.
COVID-19 vaccine tracker (click on 'Vaccines' tab). Milken Institute. 2020-05-11 [2020-05-12]. （原始内容存档于2020-06-06）. 简明摘要.
Gilgore S. Novavax's coronavirus vaccine program is getting some help from Emergent BioSolutions. Washington Business Journal. 2020-03-10 [2020-03-10]. （原始内容存档于2020-04-09）.
Sagonowsky E. Novavax scores $384M deal, CEPI's largest ever, to fund coronavirus vaccine work. FiercePharma. 2020-05-11 [2020-05-12]. （原始内容存档于2020-05-16）.
Novavax starts clinical trial of its coronavirus vaccine candidate. CNBC. 2020-05-25 [2020-05-26]. （原始内容存档于2020-05-26）.
Steenhuysen J. U.S. government awards Novavax $1.6 billion for coronavirus vaccine. Reuters. 2020-07-07 [2020-09-15]. （原始内容存档于2020-09-14）.
Thomas K, Zimmer C. Novavax Enters Final Stage of Coronavirus Vaccine Trials. The New York Times. 2020-09-24 [2020-09-28]. ISSN 0362-4331. （原始内容存档于2020-09-28）.
Phase 3 trial of Novavax investigational COVID-19 vaccine opens. National Institutes of Health (NIH). 2020-12-28 [2020-12-28]. （原始内容存档于2021-01-19）.
Lovelace B. Novavax says Covid vaccine is more than 89% effective. CNBC. 2020-01-28 [2021-04-05]. （原始内容存档于2021-01-30）.
Facher L, Joseph A. Novavax says its Covid-19 vaccine is 90% effective in late-stage trial. Stat. 2021-01-28 [2021-01-29]. （原始内容存档于2021-01-29）.
O’Donnell, Carl; Nadeem, Dania. Novavax vaccine 96% effective against original coronavirus, 86% vs British variant in UK trial. Reuters. 2021-03-11 [2021-03-23]. （原始内容存档于2021-05-04）.
诺瓦瓦克斯声称疫苗经试验100%能预防重症. SWI swissinfo.ch. 瑞士资讯. [2021-05-13]. （原始内容存档于2021-05-13）（中文）.
諾瓦瓦克斯公布其研發的新冠疫苗有效率逾九成. [2021-06-15]. （原始内容存档于2021-06-16）.
批准第8款新冠疫苗（页面存档备份，存于互联网档案馆）
新冠肺炎｜歐盟批准使用Novavax疫苗. 香港01. 2021-12-21 [2021-12-21]. （原始内容存档于2021-12-21）.
Nuvaxovid COVID-19 Vaccine (recombinant, adjuvanted). EMA. 2021-12-20 [2021-12-22]. （原始内容存档于2021-12-23）.
McCartney R. Maryland plays an outsized role in worldwide hunt for a coronavirus vaccine. Washington Post. [2020-05-08]. （原始内容存档于2020-05-07）.
Boseley S, Davis N. Novavax Covid vaccine shown to be nearly 90% effective in UK trial. The Guardian. 2021-01-28 [2021-01-29]. （原始内容存档于2021-04-12）.
Novavax signs COVID-19 vaccine supply deal with India's Serum Institute. Reuters. 2020-08-05 [2021-04-05]. （原始内容存档于2021-03-19）.
Brown M. 60m doses of new covid-19 vaccine could be made in Billingham – and be ready for mid-2021. TeesideLive (Reach). 2020-08-14 [2021-01-29]. （原始内容存档于2021-02-07）.
Spain, again chosen to produce the vaccine to combat COVID-19. This is the Real Spain. 2020-09-18 [2021-04-05]. （原始内容存档于2021-03-19）.
Novavax Deal With Mabion Boosts Poland’s Nascent Biotech Scene. Bloomberg. 2021-03-25 [2021-04-05]. （原始内容存档于2021-03-09）.
文在寅接见美国药企诺瓦瓦克斯CEO埃尔克. 韓聯社. 2021-04-27 [2021-05-02]. （原始内容存档于2021-05-02）.
Canada signs deal to produce Novavax COVID-19 vaccine at Montreal plant. CP24. 2021-02-02 [2021-02-02]. （原始内容存档于2021-04-28）.
GSK to support manufacture of Novavax Covid-19 jab at Barnard Castle facility. Express & Star. 2021-03-29 [2021-04-05]. （原始内容存档于2021-03-29）.
專家指政府有意採購第 4 款疫苗採重組蛋白技術料為「美國 Novavax」或「成都威斯克」. 立場新聞. 2021-03-13 [2021-03-13]. （原始内容存档于2021-03-14）.
諾瓦瓦克斯證實︰台灣早透過COVAX訂購疫苗. 自由時報. 2021-07-03 [2021-07-08]. （原始内容存档于2021-07-11）.
不只從COVAX取得諾瓦瓦克斯疫苗陳時中：正與原廠談判. 聯合報. 2021-07-02 [2021-07-08]. （原始内容存档于2021-07-09）.
Novavax and European Commission Finalize Advance Purchase Agreement for up to 200 million doses of COVID-19 Vaccine - Aug 4, 2021. novavax.com. 2021-08-04 [2021-08-04]. （原始内容存档于2021-08-09）（英语）.
Coronavirus: Commission approves new contract for a potential COVID-19 vaccine with Novavax. European Commission. 2021-08-04 [2021-08-04]. （原始内容存档于2020-08-25）（英语）.
Reuters. Novavax COVID-19 vaccine receives first emergency use authorization. Reuters. 2021-11-01 [2021-11-01]. （原始内容存档于2021-12-24）（英语）.
Philippines approves emergency use of Novavax's COVID-19 vaccine. Reuters. 2021-11-17 [2021-11-17]. （原始内容存档于2021-12-23）.
蘇龍麒. 陳時中證實採購Novavax疫苗逾200萬劑抵台時間待定. 中央社. 2022-03-24 [2022-06-20]. （原始内容存档于2022-06-22）.
張茗喧. 幼兒莫德納估7月中下旬開打 Novavax最快7月到貨. 中央社. 2022-06-18 [2022-06-20]. （原始内容存档于2022-06-30）.
吳亮儀. 首批50.4萬劑Novavax疫苗抵台檢驗封緘照片曝光. 自由時報. 2022-06-30 [2022-06-30]. （原始内容存档于2022-06-30）.
欧洲药管局：美国诺瓦瓦克斯新冠疫苗可能导致严重过敏. [2022-07-16]. （原始内容存档于2022-07-16）.

who.int (Global: 195^th place; Chinese: 179^th place)

extranet.who.int

批准第8款新冠疫苗（页面存档备份，存于互联网档案馆）

worldcat.org (Global: 5^th place; Chinese: 12^th place)

Novavax’s fridge-friendly vaccine impresses. Nature Biotechnology. 2021-07, 39 (7): 784–784 [2021-08-30]. ISSN 1087-0156. doi:10.1038/s41587-021-00991-8. （原始内容存档于2021-07-27）（英语）.
Wadman, Meredith. Novavax vaccine delivers 89% efficacy against COVID-19 in U.K.—but is less potent in South Africa. Science. 2021-01-28 [2021-08-30]. ISSN 0036-8075. doi:10.1126/science.abg8101. （原始内容存档于2021-05-25）.
Chung, Young Hun; Beiss, Veronique; Fiering, Steven N.; Steinmetz, Nicole F. COVID-19 Vaccine Frontrunners and Their Nanotechnology Design. ACS Nano. 2020-10-09 [2021-08-30]. ISSN 1936-0851. PMC 7553041 . PMID 33034449. doi:10.1021/acsnano.0c07197. （原始内容存档于2021-10-19）.
Thomas K, Zimmer C. Novavax Enters Final Stage of Coronavirus Vaccine Trials. The New York Times. 2020-09-24 [2020-09-28]. ISSN 0362-4331. （原始内容存档于2020-09-28）.
Keech, Cheryl; Albert, Gary; Cho, Iksung; Robertson, Andreana; Reed, Patricia; Neal, Susan; Plested, Joyce S.; Zhu, Mingzhu; Cloney-Clark, Shane. Phase 1–2 Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine. New England Journal of Medicine. 2020-12-10, 383 (24): 2320–2332. ISSN 0028-4793. PMC 7494251 . PMID 32877576. doi:10.1056/NEJMoa2026920.

yna.co.kr (Global: 981^st place; Chinese: 190^th place)

m-cn.yna.co.kr

文在寅接见美国药企诺瓦瓦克斯CEO埃尔克. 韓聯社. 2021-04-27 [2021-05-02]. （原始内容存档于2021-05-02）.

诺瓦瓦克斯2019冠状病毒病疫苗 (Chinese Wikipedia)

163.com (Global: 372nd place; Chinese: 16th place)

bbc.com (Global: 20th place; Chinese: 41st place)

bizjournals.com (Global: 407th place; Chinese: 1,299th place)

bloomberg.com (Global: 99th place; Chinese: 225th place)

clinicaltrials.gov (Global: 5,225th place; Chinese: 4,888th place)

cna.com.tw (Global: 527th place; Chinese: 24th place)

cnbc.com (Global: 220th place; Chinese: 426th place)

cp24.com (Global: 8,625th place; Chinese: 8,137th place)

docs.google.com (Global: 1,047th place; Chinese: 1,169th place)

doi.org (Global: 2nd place; Chinese: 23rd place)

europa.eu (Global: 68th place; Chinese: 209th place)

ema.europa.eu

ec.europa.eu

expressandstar.com (Global: 3,534th place; Chinese: 7,097th place)

fancycomma.com (Global: low place; Chinese: low place)

fiercepharma.com (Global: low place; Chinese: low place)

gazettelive.co.uk (Global: 5,758th place; Chinese: low place)

harvard.edu (Global: 18th place; Chinese: 57th place)

ui.adsabs.harvard.edu

hk01.com (Global: 379th place; Chinese: 11th place)

indiatoday.in (Global: 94th place; Chinese: 1,782nd place)

livemint.com (Global: 390th place; Chinese: 4,697th place)

ltn.com.tw (Global: 302nd place; Chinese: 6th place)

news.ltn.com.tw

milkeninstitute.org (Global: low place; Chinese: low place)

nature.com (Global: 234th place; Chinese: 227th place)

nih.gov (Global: 4th place; Chinese: 5th place)

ncbi.nlm.nih.gov

nih.gov

novavax.com (Global: low place; Chinese: low place)

novavax.com

ir.novavax.com

nytimes.com (Global: 7th place; Chinese: 31st place)

reuters.com (Global: 49th place; Chinese: 81st place)

rthk.hk (Global: 2,797th place; Chinese: 109th place)

news.rthk.hk

sciencemag.org (Global: 857th place; Chinese: 506th place)

statnews.com (Global: 8,771st place; Chinese: 9,752nd place)

swissinfo.ch (Global: 1,485th place; Chinese: 1,674th place)

theguardian.com (Global: 12th place; Chinese: 60th place)

thestandnews.com (Global: 4,504th place; Chinese: 168th place)

thisistherealspain.com (Global: low place; Chinese: low place)

udn.com (Global: 392nd place; Chinese: 10th place)

un.org (Global: 97th place; Chinese: 122nd place)

news.un.org

washingtonpost.com (Global: 34th place; Chinese: 129th place)

web.archive.org (Global: 1st place; Chinese: 1st place)

who.int (Global: 195th place; Chinese: 179th place)

extranet.who.int

worldcat.org (Global: 5th place; Chinese: 12th place)

yna.co.kr (Global: 981st place; Chinese: 190th place)

m-cn.yna.co.kr

163.com (Global: 372^nd place; Chinese: 16^th place)

bbc.com (Global: 20^th place; Chinese: 41^st place)

bizjournals.com (Global: 407^th place; Chinese: 1,299^th place)

bloomberg.com (Global: 99^th place; Chinese: 225^th place)

clinicaltrials.gov (Global: 5,225^th place; Chinese: 4,888^th place)

cna.com.tw (Global: 527^th place; Chinese: 24^th place)

cnbc.com (Global: 220^th place; Chinese: 426^th place)

cp24.com (Global: 8,625^th place; Chinese: 8,137^th place)

docs.google.com (Global: 1,047^th place; Chinese: 1,169^th place)

doi.org (Global: 2^nd place; Chinese: 23^rd place)

europa.eu (Global: 68^th place; Chinese: 209^th place)

expressandstar.com (Global: 3,534^th place; Chinese: 7,097^th place)

gazettelive.co.uk (Global: 5,758^th place; Chinese: low place)

harvard.edu (Global: 18^th place; Chinese: 57^th place)

hk01.com (Global: 379^th place; Chinese: 11^th place)

indiatoday.in (Global: 94^th place; Chinese: 1,782^nd place)

livemint.com (Global: 390^th place; Chinese: 4,697^th place)

ltn.com.tw (Global: 302^nd place; Chinese: 6^th place)

nature.com (Global: 234^th place; Chinese: 227^th place)

nih.gov (Global: 4^th place; Chinese: 5^th place)

nytimes.com (Global: 7^th place; Chinese: 31^st place)

reuters.com (Global: 49^th place; Chinese: 81^st place)

rthk.hk (Global: 2,797^th place; Chinese: 109^th place)

sciencemag.org (Global: 857^th place; Chinese: 506^th place)

statnews.com (Global: 8,771^st place; Chinese: 9,752^nd place)

swissinfo.ch (Global: 1,485^th place; Chinese: 1,674^th place)

theguardian.com (Global: 12^th place; Chinese: 60^th place)

thestandnews.com (Global: 4,504^th place; Chinese: 168^th place)

udn.com (Global: 392^nd place; Chinese: 10^th place)

un.org (Global: 97^th place; Chinese: 122^nd place)

washingtonpost.com (Global: 34^th place; Chinese: 129^th place)

web.archive.org (Global: 1^st place; Chinese: 1^st place)

who.int (Global: 195^th place; Chinese: 179^th place)

worldcat.org (Global: 5^th place; Chinese: 12^th place)

yna.co.kr (Global: 981^st place; Chinese: 190^th place)